- 全部删除
您的购物车当前为空
STM3006 是一种具有口服活性、选择性和和高效性的 METTL3 抑制剂,具有抗肿瘤活性,可用于研究急性髓系白血病(AML)。


为众多的药物研发团队赋能,
让新药发现更简单!
STM3006 是一种具有口服活性、选择性和和高效性的 METTL3 抑制剂,具有抗肿瘤活性,可用于研究急性髓系白血病(AML)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 768 | In stock | |
| 5 mg | ¥ 1,880 | In stock | |
| 10 mg | ¥ 2,730 | In stock | |
| 25 mg | ¥ 4,470 | In stock | |
| 50 mg | ¥ 6,290 | In stock | |
| 100 mg | ¥ 8,480 | In stock | |
| 200 mg | ¥ 11,300 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,170 | In stock |
STM3006 相关产品
| 产品描述 | STM3006 is an orally active, selective and and potent METTL3 inhibitor with antitumor activity for the study of acute myeloid leukemia (AML). |
| 分子量 | 519.44 |
| 分子式 | C25H27BrN8 |
| CAS No. | 2499664-52-5 |
| Smiles | BrC=1C=C2NN=CC2=C(C1)C=3N=NN(C3)CC=4N=C5C=CC(=CN5C4)CN6CCC(C)(C)CC6 |
| 密度 | 1.54 g/cm3 at 20℃ (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (154.01 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容